Jo W.M. Höppener

7.6k total citations · 1 hit paper
92 papers, 5.8k citations indexed

About

Jo W.M. Höppener is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Jo W.M. Höppener has authored 92 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 31 papers in Endocrinology, Diabetes and Metabolism and 28 papers in Surgery. Recurrent topics in Jo W.M. Höppener's work include Neuroendocrine Tumor Research Advances (23 papers), Pancreatic function and diabetes (18 papers) and Alzheimer's disease research and treatments (17 papers). Jo W.M. Höppener is often cited by papers focused on Neuroendocrine Tumor Research Advances (23 papers), Pancreatic function and diabetes (18 papers) and Alzheimer's disease research and treatments (17 papers). Jo W.M. Höppener collaborates with scholars based in Netherlands, United States and Sweden. Jo W.M. Höppener's co-authors include Cornelis J.M. Lips, Bo Åhrén, H.S. Jansz, J. Antoinette Killian, Maarten F. M. Engel, P.H. Steenbergh, J. Zandberg, Hans Kristian Ploos van Amstel, Rudy M. Landsvater and Ben de Kruijff and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Jo W.M. Höppener

91 papers receiving 5.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

1994 872 citations Jo W.M. Höppener et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jo W.M. Höppener Netherlands	37	2.9k	1.6k	1.5k	1.3k	1.1k	92	5.8k
Cornelis J.M. Lips Netherlands	37	1.8k 0.6×	1.5k 0.9×	628 0.4×	1.0k 0.8×	960 0.9×	96	4.5k
Andrea Graziani Italy	34	3.9k 1.4×	465 0.3×	1.3k 0.8×	851 0.6×	999 0.9×	97	7.3k
William F. Simonds United States	45	4.0k 1.4×	443 0.3×	409 0.3×	498 0.4×	1.2k 1.2×	138	6.5k
Rosemary O’Connor Ireland	39	3.1k 1.1×	751 0.5×	852 0.6×	279 0.2×	841 0.8×	99	5.3k
Giuseppe Damante Italy	49	5.2k 1.8×	2.0k 1.3×	323 0.2×	705 0.5×	1.6k 1.5×	288	8.7k
Dennis D. Cunningham United States	46	3.8k 1.3×	355 0.2×	1.4k 0.9×	654 0.5×	692 0.7×	104	7.8k
Christian Bruns Switzerland	41	3.2k 1.1×	1.8k 1.1×	348 0.2×	1.1k 0.9×	1.7k 1.6×	98	7.9k
Ruth Maron United States	40	1.8k 0.6×	451 0.3×	1.1k 0.7×	533 0.4×	537 0.5×	73	5.1k
Samuel E. Lux United States	53	3.5k 1.2×	794 0.5×	3.9k 2.6×	1.4k 1.0×	249 0.2×	114	9.4k
Thomas Braulke Germany	43	3.1k 1.1×	1.0k 0.6×	2.8k 1.9×	370 0.3×	215 0.2×	174	6.5k

Countries citing papers authored by Jo W.M. Höppener

Since Specialization

Citations

This map shows the geographic impact of Jo W.M. Höppener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo W.M. Höppener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo W.M. Höppener more than expected).

Fields of papers citing papers by Jo W.M. Höppener

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo W.M. Höppener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo W.M. Höppener. The network helps show where Jo W.M. Höppener may publish in the future.

Co-authorship network of co-authors of Jo W.M. Höppener

This figure shows the co-authorship network connecting the top 25 collaborators of Jo W.M. Höppener. A scholar is included among the top collaborators of Jo W.M. Höppener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo W.M. Höppener. Jo W.M. Höppener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Versteeg, Sabine, J. Henk Coert, Judith Prado, et al.. (2023). Human IAPP is a contributor to painful diabetic peripheral neuropathy. Journal of Clinical Investigation. 133(8). 4 indexed citations

Dreijerink, Koen M.A., Radhika A. Varier, Olivier van Beekum, et al.. (2009). The Multiple Endocrine Neoplasia Type 1 (MEN1) Tumor Suppressor Regulates Peroxisome Proliferator-Activated Receptor γ-Dependent Adipocyte Differentiation. Molecular and Cellular Biology. 29(18). 5060–5069. 53 indexed citations

Timmerman, Peter, Rodrigo Barderas, Johan Desmet, et al.. (2009). A Combinatorial Approach for the Design of Complementarity-determining Region-derived Peptidomimetics with in Vitro Anti-tumoral Activity. Journal of Biological Chemistry. 284(49). 34126–34134. 32 indexed citations

Lips, Cornelis J.M., Wendy van Veelen, Thera P. Links, & Jo W.M. Höppener. (2009). Multiple endocrine neoplasia type 2. Expert Review of Endocrinology & Metabolism. 4(5). 443–465. 1 indexed citations

Veelen, Wendy van, Dennis S. Acton, David S. Franklin, et al.. (2008). Synergistic Effect of Oncogenic RET and Loss of p18 on Medullary Thyroid Carcinoma Development. Cancer Research. 68(5). 1329–1337. 37 indexed citations

Gujral, Taranjit S., Wendy van Veelen, Douglas S. Richardson, et al.. (2008). A Novel RET Kinase–β-Catenin Signaling Pathway Contributes to Tumorigenesis in Thyroid Carcinoma. Cancer Research. 68(5). 1338–1346. 57 indexed citations

Engel, Maarten F. M., Lucie Khemtémourian, Hans Meeldijk, et al.. (2008). Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane. Proceedings of the National Academy of Sciences. 105(16). 6033–6038. 409 indexed citations

Norton, David L., et al.. (2006). Simultaneous downregulation of CDK inhibitors p18Ink4c and p27Kip1 is required for MEN2A-RET-mediated mitogenesis. Oncogene. 26(4). 554–570. 29 indexed citations

Lips, Cornelis J.M., et al.. (2004). Espectro de tumores y síndromes carcinoides. Acta bioquímica clínica latinoamericana. 38(1). 47–59. 1 indexed citations

10.

Sparr, Emma, Maarten F. M. Engel, M. Sprong, et al.. (2004). Islet amyloid polypeptide‐induced membrane leakage involves uptake of lipids by forming amyloid fibers. FEBS Letters. 577(1-2). 117–120. 221 indexed citations

11.

Hes, Frederik J., Jo W.M. Höppener, & Cornelis J.M. Lips. (2003). Pheochromocytoma in Von Hippel-Lindau Disease. The Journal of Clinical Endocrinology & Metabolism. 88(3). 969–974. 63 indexed citations

12.

Rijkers, Dirk T. S., Jo W.M. Höppener, George Posthuma, Cornelis J.M. Lips, & Rob M. J. Liskamp. (2002). Inhibition of Amyloid Fibril Formation of Human Amylin by N-Alkylated Amino Acid and -Hydroxy Acid Residue Containing Peptides. Chemistry - A European Journal. 8(18). 4285–4291. 67 indexed citations

13.

Höppener, Jo W.M., Cor Oosterwijk, M. G. Nieuwenhuis, et al.. (1999). Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Diabetologia. 42(4). 427–434. 127 indexed citations

14.

Oosterwijk, Cor, et al.. (1997). Pancreatic cancer in rats and hamsters does not induce IAPP-related hyperglycaemia. International Journal of Cancer. 72(4). 637–641. 4 indexed citations

15.

Elderson, A., D. Wittebol‐Post, Ronald J. Hené, et al.. (1994). Von hippel-lindau disease: New strategies in early detection and treatment. The American Journal of Medicine. 97(2). 158–168. 66 indexed citations

16.

Höppener, Jo W.M., H.S. Jansz, Cor Oosterwijk, et al.. (1994). Molecular physiology of the islet amyloid polypeptide (IAPP)/amylin gene in man, rat, and transgenic mice. Journal of Cellular Biochemistry. 55(S1994A). 39–53. 35 indexed citations

17.

Mosselman, Sietse, Jo W.M. Höppener, C.J.M. Lips, & H.S. Jansz. (1989). The complete islet amyloid polypeptide precursor is encoded by two exons. FEBS Letters. 247(1). 154–158. 58 indexed citations

18.

Höppener, Jo W.M., P.H. Steenbergh, J. Zandberg, et al.. (1988). A third human CALC (pseudo)gene on chromosome 11. FEBS Letters. 233(1). 57–63. 17 indexed citations

19.

Baylin, Stephen B., Jo W.M. Höppener, A de Bustros, et al.. (1986). DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas.. PubMed. 46(6). 2917–22. 174 indexed citations

20.

Pagter-Holthuizen, P. de, Jo W.M. Höppener, M. Jansen, et al.. (1985). Chromosomal localization and preliminary characterization of the human gene encoding insulin-like growth factor II. Human Genetics. 69(2). 170–173. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact